Tag: angiotensin ii receptor blockade

‘Quadpill’ Bests Monotherapy for Initial BP Lowering: QUARTET

A “quadpill” containing quarter doses of four blood pressure (BP)-lowering medications was more effective than monotherapy for initial treatment of hypertension, with similar tolerability, in...

Did Unrecognized Cardiac Amyloidosis Hinder Recent HFpEF Trials?

Screening for cardiac amyloidosis and excluding patients with cardiac amyloidosis from trials of new therapies for heart failure with preserved ejection fraction (HFpEF) may increase...

Novel Drug Slows Progression of Diabetic Kidney Disease

For patients with diabetic kidney disease, finerenone, an agent from a new class of selective, nonsteroidal mineralocorticoid receptor antagonists, led to significant reductions in combined...

Nine Antihypertensive Drugs Associated With Reduced Risk for Depression

The risk of depression is elevated in patients with cardiovascular diseases, but several specific antihypertensive therapies are associated with a reduced risk, and none appear...

Low-Dose Antihypertensive Combo Improves Blood Pressure Control

NEW YORK (Reuters Health) – A low-dose fixed-dose combination of three antihypertensive drugs improves blood pressure control but is associated with greater rates of therapeutic...

Antihypertensives Linked to Reduced Risk of Colorectal Cancer

Treating hypertension with angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) was associated with a reduced risk for colorectal cancer, according to findings from...

Angiotensin Drugs and COVID-19: More Reassuring Data

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Initial data from one Chinese center on the use of angiotensin-converting...

Evidence of Possible RAS-Blocker Benefit in Patients With COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s  Coronavirus Resource Center. Patients infected by the COVID-19 virus may benefit from treatments that...

New Registry to Zero In on CVD Role in COVID-19 Pandemic

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s  Coronavirus Resource Center. A new registry has been created to standardize data collection on...

Stay on Angiotensin Drugs’ Still the Message as Trials Begin

What your doctor is reading on Medscape.com: APRIL 06, 2020 — Much remains unknown about the novel coronavirus SARS-CoV-2 and the disease it...

‘Stay on Angiotensin Drugs’ Still the Message as Trials Begin

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s  Coronavirus Resource Center. Much remains unknown about the novel coronavirus SARS-CoV-2 and the disease...